Biodelivery Sciences International reported $63.91M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 15.19M 0.36M
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Agile Therapeutics AGRX:US $ 11.64M 2.85M
Alimera Sciences ALIM:US $ 10.31M 0.9M
Antares Pharma ATRS:US $ 71.97M 0.17M
Biodelivery Sciences International BDSI:US $ 63.91M 9.32M
Cara Therapeutics CARA:US $ 15.17M 1.35M
Cti Biopharma CTIC:US $ 15.79M 0.23M
Daiichi Sankyo 4568:JP Y 332771M 20800M
Depomed DEPO:US $ 116.91M 7.82M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Knight Therapeutics Inc GUD:CN C$ 117.77M 18.17M
Lannett LCI:US $ 90.47M 6.66M
Mannkind MNKD:US $ 60.43M 12.69M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Redhill Biopharma RDHL:US $ 79.17M 12.54M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Teva Pharmaceutical TEVA:IT 12.69B 602M